Cargando…
Reply to Yilmaz: Selection of Biologics for Type 2–High Asthma
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Thoracic Society
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6775882/ https://www.ncbi.nlm.nih.gov/pubmed/31106571 http://dx.doi.org/10.1164/rccm.201904-0898LE |
| _version_ | 1783456340596752384 |
|---|---|
| author | McGregor, Mary Clare Krings, James Nair, Parameswaran Castro, Mario |
| author_facet | McGregor, Mary Clare Krings, James Nair, Parameswaran Castro, Mario |
| author_sort | McGregor, Mary Clare |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6775882 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | American Thoracic Society |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-67758822019-10-04 Reply to Yilmaz: Selection of Biologics for Type 2–High Asthma McGregor, Mary Clare Krings, James Nair, Parameswaran Castro, Mario Am J Respir Crit Care Med Correspondence American Thoracic Society 2019-09-15 2019-09-15 /pmc/articles/PMC6775882/ /pubmed/31106571 http://dx.doi.org/10.1164/rccm.201904-0898LE Text en Copyright © 2019 by the American Thoracic Society https://creativecommons.org/licenses/by-nc-nd/4.0/This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License 4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/). For commercial usage and reprints, please contact Diane Gern (dgern@thoracic.org) |
| spellingShingle | Correspondence McGregor, Mary Clare Krings, James Nair, Parameswaran Castro, Mario Reply to Yilmaz: Selection of Biologics for Type 2–High Asthma |
| title | Reply to Yilmaz: Selection of Biologics for Type 2–High Asthma |
| title_full | Reply to Yilmaz: Selection of Biologics for Type 2–High Asthma |
| title_fullStr | Reply to Yilmaz: Selection of Biologics for Type 2–High Asthma |
| title_full_unstemmed | Reply to Yilmaz: Selection of Biologics for Type 2–High Asthma |
| title_short | Reply to Yilmaz: Selection of Biologics for Type 2–High Asthma |
| title_sort | reply to yilmaz: selection of biologics for type 2–high asthma |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6775882/ https://www.ncbi.nlm.nih.gov/pubmed/31106571 http://dx.doi.org/10.1164/rccm.201904-0898LE |
| work_keys_str_mv | AT mcgregormaryclare replytoyilmazselectionofbiologicsfortype2highasthma AT kringsjames replytoyilmazselectionofbiologicsfortype2highasthma AT nairparameswaran replytoyilmazselectionofbiologicsfortype2highasthma AT castromario replytoyilmazselectionofbiologicsfortype2highasthma |